EC144 Is a Potent Inhibitor of the Heat Shock Protein 90

被引:54
|
作者
Shi, Jiandong [1 ]
Van de Water, Ryan [1 ]
Hong, Kevin [1 ]
Lamer, Ryan B. [1 ]
Weichert, Kenneth W. [1 ]
Sandoval, Cristina M. [1 ]
Kasibhatla, Srinivas R. [1 ]
Boehm, Marcus F. [1 ]
Chao, Jianhua [1 ]
Lundgren, Karen [1 ]
Timple, Noelito [1 ]
Lough, Rachel [1 ]
Ibanez, Gerardo [1 ]
Boykin, Christina [1 ]
Burrows, Francis J. [1 ]
Kehry, Marilyn R. [1 ]
Yun, Theodore J. [1 ]
Harning, Erin K. [1 ]
Ambrose, Christine [2 ]
Thompson, Jeffrey [2 ]
Bixler, Sarah A. [2 ]
Dunah, Anthone [2 ]
Snodgrass-Belt, Pamela [2 ]
Arndt, Joseph [2 ]
Enyedy, Istvan J. [2 ]
Li, Ping [2 ]
Hong, Victor S. [2 ]
McKenzie, Andres [2 ]
Biamonte, Marco A. [1 ]
机构
[1] Biogen Idec Inc, San Diego, CA 92122 USA
[2] Biogen Idec Inc, Cambridge, MA 02142 USA
关键词
HSP90; INHIBITOR; BREAST-CANCER; ANTITUMOR ACTIVITIES; EXHIBITS POTENT; MYELOMA; DESIGN; HEAT-SHOCK-PROTEIN-90; TANESPIMYCIN; DERIVATIVES; MECHANISM;
D O I
10.1021/jm300810x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Alkyne 40, 5-(2-amino-4-chloro-7-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-methylpent-4-yn-2-ol (EC144), is a second generation inhibitor of heat shock protein 90 (Hsp90) and is substantially more potent in vitro and in vivo than the first generation inhibitor 14 (BIIB021) that completed phase II clinical trials. Alkyne 40 is more potent than 14 in an Hsp90 alpha binding assay (IC50 = 1.1 vs 5.1 nM) as well as in its ability to degrade Her-2 in MCF-7 cells (EC50 = 14 vs 38 nM). In a mouse model of gastric tumors (N87), 40 stops tumor growth at 5 mg/kg and causes partial tumor regressions at 10 mg/kg (po, qdx5). Under the same conditions, 14 stops tumor growth only at 120 mg/kg, and does not induce partial regressions. Thus, alkyne 40 is approximately 20-fold more efficacious than 14 in mice.
引用
收藏
页码:7786 / 7795
页数:10
相关论文
共 50 条
  • [21] Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90
    He, HZ
    Zatorska, D
    Kim, J
    Aguirre, J
    Llauger, L
    She, YH
    Wu, N
    Immormino, RM
    Gewirth, DT
    Chiosis, G
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (01) : 381 - 390
  • [22] Presence of an aromatase inhibitor, possibly heat shock protein 90, in dominant follicles of cattle
    Driancourt, MA
    Guet, P
    Reynaud, K
    Chadli, A
    Catelli, MG
    JOURNAL OF REPRODUCTION AND FERTILITY, 1999, 115 (01): : 45 - 58
  • [23] Preferential Sensitization of tumor cells to radiation by heat shock protein 90 inhibitor geldanamycin
    Matsumoto, Y
    Machida, H
    Kubota, N
    JOURNAL OF RADIATION RESEARCH, 2005, 46 (02) : 215 - 221
  • [24] The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin
    Rajinder Kumar
    Alla Musiyenko
    Sailen Barik
    Malaria Journal, 2
  • [25] FEASIBILITY AND OUTCOMES OF PARTIAL NEPHRECTOMY FOLLOWING THERAPY WITH A HEAT SHOCK PROTEIN 90 INHIBITOR
    Williams, Heinric
    Krill, Aaron
    Fowler, Sally
    Neckers, Leonard
    Pinto, Peter A.
    Ivy, Percy
    Srinivasan, Ramaprasand
    Linehan, W. Marston
    Bratslavsky, Gennady
    JOURNAL OF UROLOGY, 2010, 183 (04): : E386 - E386
  • [26] Identification and characterisation of a novel heat shock protein 90 inhibitor ONO4140
    Eachkoti, Rafiqa
    Reddy, M. V. Ramana
    Lieu, Yen K.
    Cosenza, Stephen C.
    Reddy, E. PremKumar
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (11) : 1982 - 1992
  • [27] Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90) (vol 21, pg 7047, 2013)
    Brasca, Maria Gabriella
    Mantegani, Sergio
    Amboldi, Nadia
    Bindi, Simona
    Caronni, Dannica
    Casale, Elena
    Ceccarelli, Walter
    Colombo, Nicoletta
    De Ponti, Anna
    Donati, Daniele
    Ermoli, Antonella
    Fachin, Gabriele
    Felder, Eduard R.
    Ferguson, Ronald D.
    Fiorelli, Claudio
    Guanci, Marco
    Isacchi, Antonella
    Pesenti, Enrico
    Polucci, Paolo
    Riceputi, Laura
    Sola, Francesco
    Visco, Carlo
    Zuccotto, Fabio
    Fogliatto, Gianpaolo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (01) : 662 - 662
  • [28] Heat shock protein 90 is an endogenous protein inhibitor of superoxide generation from nitric oxide synthase
    Song, Y
    Cardounel, AJ
    Zweier, JL
    Xia, Y
    CIRCULATION, 2001, 104 (17) : 99 - 99
  • [29] Heat Shock Protein 90 (Hsp90)-Inhibitor-Luminespib-Loaded-Protein-Based Nanoformulation for Cancer Therapy
    K. Rochani, Ankit
    Balasubramanian, Sivakumar
    Ravindran Girija, Aswathy
    Maekawa, Toru
    Kaushal, Gagan
    Kumar, D. Sakthi
    POLYMERS, 2020, 12 (08)
  • [30] Heat Shock Protein 90 (Hsp90) Preface
    Picard, Didier
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (03): : 605 - 606